BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lin L, Zhang P, Wang YY, Cai YF, Wen LB, Chen WP, Xiao YF, Li ZK, Liu GY. Early vs conventional initiation of adjuvant chemotherapy in advanced gastric cancer: A propensity-matched outcomes study. World J Gastroenterol 2025; 31(42): 110069 [PMID: 41278157 DOI: 10.3748/wjg.v31.i42.110069]
URL: https://www.wjgnet.com/1007-9327/full/v31/i42/110069.htm
Number Citing Articles
1
Shi-Qiong Zhou, Qing-Hua Ke. Rethinking the timing of adjuvant chemotherapy in advanced gastric cancer: From feasibility to precision sequencingWorld Journal of Gastrointestinal Oncology 2026; 18(9): 118773 doi: 10.4251/wjgo.118773
2
Le Zhang, Li-Ping Liang, Dan-Dan Jin, Min Lu, Ying Deng, Shao-Heng Zhang, Xin-Ying Wang, Le Liu. Letter to the Editor: Ultra-early adjuvant chemotherapy after gastrectomy: Dose intensity, peritoneal recurrence, and evidence gapsWorld Journal of Gastroenterology 2026; 32(38): 115891 doi: 10.3748/wjg.115891
3
Jing-Jing Dai, Jun-Wen Cai, Xiao-Guang Xu, Guo-Quan Tao, Wen-Jun Mao. Shortening the hiatus: A preliminary challenge to the 4-6 weeks paradigm in adjuvant gastric cancer therapyWorld Journal of Gastrointestinal Oncology 2026; 18(9): 115778 doi: 10.4251/wjgo.115778